Another study reported that nonsteroidal anti-inflammatory drugs (NSAIDS) inhibit TCF-1/β-catenin mediated downstream target genes such as cyclin D1 and thereby inhibits growth of colorectal cancer cells [41]. This evidence concerns the gene CCND1 and colorectal cancer.